Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies
Susanne Hansen, Marianne Baastrup Soendergaard, Anna von Bülow, et al.
CHEST Journal (2023) Vol. 165, Iss. 2, pp. 253-266
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults
Luis Pérez de Llano, Ghislaine Scélo, Trung N. Tran, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 7, pp. 869-880
Open Access | Times Cited: 28
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis
Corrado Pelaia, Claudia Crimi, Alida Benfante, et al.
Respirology (2024) Vol. 29, Iss. 10, pp. 869-879
Open Access | Times Cited: 13
Association between pre-biologic T2-Biomaker combinations and response to biologics in patients with severe asthma
Celeste Porsbjerg, Jonathan N. Townend, Céline Bergeron, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
Ghislaine Scélo, Trung N. Tran, Tham Le, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2347-2361
Open Access | Times Cited: 8
Effect of Azithromycin on Asthma Remission in Adults With Persistent Uncontrolled Asthma
Dennis Thomas, Vanessa M. McDonald, Sean Stevens, et al.
CHEST Journal (2024) Vol. 166, Iss. 2, pp. 262-270
Open Access | Times Cited: 7
Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis
Amy Shackleford, Liam G. Heaney, Charlene Redmond, et al.
The Lancet Respiratory Medicine (2024)
Open Access | Times Cited: 6
Clinical remission in severe asthma: lights and shadows on an ambitious goal
Corrado Pelaia, Eleonora Zannoni, Giovanni Paoletti, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 4, pp. 230-236
Closed Access | Times Cited: 5
Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities
Alessandro Vatrella, Angelantonio Maglio
Expert Review of Respiratory Medicine (2025)
Closed Access
Biologics in severe asthma: a state-of-the-art review
Bishal Gyawali, Steve N. Georas, Sandhya Khurana
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240088-240088
Open Access
Clinical Remission of Mild-to-Moderate Asthma: Rates, Contributing Factors, and Stability
Mana Ishizuka, Naoya Sugimoto, Konomi Kobayashi, et al.
Journal of Allergy and Clinical Immunology Global (2025), pp. 100431-100431
Open Access
Eosinophilic chronic rhinosinusitis as a predictor of super-responder and clinical remission in patients with uncontrolled type 2-high severe asthma treated with biologics
Satoshi Hamada, Eriko Ogino, Hirotaka Yasuba
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 247-251
Closed Access
Reply to: Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects
Neil Martin, Michael E. Wechsler, Christopher E. Brightling
European Respiratory Journal (2025) Vol. 65, Iss. 2, pp. 2402434-2402434
Open Access
Recent evidence for stepping down severe asthma therapies
Eric Merrell, Sandhya Khurana
Current Opinion in Pulmonary Medicine (2025)
Closed Access
WHAT WE KNOW TO DATE ABOUT EARLY TREATMENT WITH BIOLOGICS IN SEVERE ASTHMA
Luis Pérez de Llano, Mary Ann Bonilla, Elisa Luzón, et al.
Open Respiratory Archives (2025) Vol. 7, Iss. 2, pp. 100418-100418
Open Access
Supratherapeutic Inhaled Corticosteroid Use in Patients Initiating on Biologic Therapies for Severe Asthma: A Nationwide Cohort Study
Frederikke Hjortdahl, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
Lung (2025) Vol. 203, Iss. 1
Open Access
Pro: Clinical remission in asthma – implications for asthma management
Stefania Principe, Nizar N. Jarjour
European Respiratory Review (2025) Vol. 34, Iss. 176, pp. 240181-240181
Open Access
Who really responds to asthma biologics? The clue lies in the journey before treatment
Freda Yang, Apostolos Bossios
European Respiratory Journal (2025) Vol. 65, Iss. 4, pp. 2500044-2500044
Closed Access
Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study
Piotr Damiański, Adam Białas, Marta Kołacińska-Flont, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 887-887
Open Access
Immune Cell-Mediated Autoimmune Responses in Severe Asthma
Thi Bich Tra Cao, Quang Luu Quoc, Jae-Hyuk Jang, et al.
Yonsei Medical Journal (2024) Vol. 65, Iss. 4, pp. 194-194
Open Access | Times Cited: 4
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study
Claudia Crimi, Santi Nolasco, Alberto Noto, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 12, pp. 3315-3327
Open Access | Times Cited: 4
Identifying Super-Responders: a Review of the Road to Asthma Remission
Samuel Mailhot-Larouche, C.A. Celis-Preciado, Liam G. Heaney, et al.
Annals of Allergy Asthma & Immunology (2024)
Open Access | Times Cited: 4
PI3K Pathway Activation in Severe Asthma is Linked to Steroid Insensitivity and Adverse Outcomes
Sekiko Uehara, Keita Hirai, Toshihiro Shirai, et al.
Journal of Allergy and Clinical Immunology Global (2025) Vol. 4, Iss. 2, pp. 100439-100439
Open Access
Biologics and biomarkers
L. Nair, Rohit Katial
Journal of Precision Respiratory Medicine (2025) Vol. 8, Iss. 1, pp. 3-8
Open Access
Efficacy and Safety of Biologic Therapies in Severe Asthma: A Comparative Analysis of Treatment Outcomes in Pediatric and Adult Populations
Muhammad Asad, Yasser Osman, Saeed Nazari Soltan Ahmad, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 3, pp. 329-335
Closed Access
ERS Congress 2024: highlights from the Airway Diseases Assembly
Clarice X. Lim, Reshed Abohalaka, Ran Wang, et al.
ERJ Open Research (2025) Vol. 11, Iss. 2, pp. 01255-2024
Open Access
Page 1 - Next Page

Scroll to top